STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION OF FIMASARTAN BY REVERSE-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY IN BULK AND PHARMACEUTICAL DOSAGE FORM
Keywords:Fimasartan, Reverse-phase high-performance liquid chromatography,, C18 column
Objective: A rapid, sensitive and specific reverse phase High performance liquid Chromatography (RP-HPLC) method was developed for the estimation of Fimasartan in bulk and pharmaceutical dosage form.
Method: The RP-HPLC analysis was performed isocratically on a Primacel C18 column (150 mm × 4.6 mm internal diameter, 5 μm particle size) using mobile phase of composition Acetonitrile and 0.1% orthophosphoric Acid in 80:20, v/v proportions with a flow rate of 0.8 ml/min.
Results: The analyte was monitered with UV-detector at 265 nm. In the developed method Fimasartan elutes at a typical retention time of 2.4 min. The proposed method is having linearity in the concentration ranging from 5-30 μg/ml of Fimasartan.
Conclusion: : The method was statistically validated and had been applied to analysis of the drug in bulk and pharmaceutical dosage form.
Sharma BK. Introduction to analytical chemistry. In: Instrumental Methods of Chemical Analysis. Vol. 23. Meerut: Goel Publishing House; 2012. p. 9-303.
Pandya CP, Rajput SJ. Validated stability indicating RP-HPLC method for the determination of fimasartan in presence of degradation products. Indo Am J Pharm Res 2017;7:929-46.
Moon HW, Yousaf AM, Cho KH, Yong CS. Evaluation of stability and simultaneous determination of fimasartan and amlodipine by a HPLC method in combination tablets. Asian J Pharm Sci 2014;9:123-8.
Mohammed AB, Rudwan EH. RP-HPLC method development and validation of stability indicating method a for estimation of losartan potassium under stress condition and tablet dosage form. Int J Pharm Sci Res 2016;7:2343-51.
Sumithra M, Shanmugasundaram P, Sankar AS, Niharika. Method development and validation of losartan potassium by RP-HPLC. Res J Pharm Biol Chem Sci 2012;3:463-78.
Paladugu ND, Rao GD, Satyanarayana B, Poloju D. Development and validation of RP-HPLC method for quantification of valsartan and its pharmaceutical formulations. Int J Drug Dev Res 2013;5:199-205.
Pal R, Padma S, Bhargav Y, Reddy GR. RP-HPLC method development and validation of valsartan in bulk and its tablet dosage form. J Biomed Pharm Sci 2019;2:122.
Vinzuda DU, Sailor GU, Sheth NR. RP-HPLC method for determination of valsartan in tablet dosage form. Int J ChemTech Res 2010;2:1461-7.
Haque MA, Amrohi SH, Kumar KP, Nivedita G, Kumar TP, Mohanty D,et al. Stability indicating RP-HPLC method for the estimation of valsartan in pharmaceutical dosage form. IOSR J Pharm 2012;2:12-8.
Siddiqui MM, Qasim SS, Abueida EY. Isocratic RP-HPLC method validation and verification of losartan potassium in pharmaceutical formulations with stress test stability for drug substance. Der Pharm Lett 2011;3:160-7.
Panigrahy UP, Kumari KN, Reddy T, Abbulu K. RP-HPLC method development and validation for simultaneous estimation of prazosin and polythiazide in bulk and pharmaceutical dosage form. Res J Pharm Technol 2020;13:1779-89.
Masthanamma SK, Pradeepthi, Jahnavi. Stability indicating RP-HPLC method for determination of azilsartan medoxomil in pharmaceutical dosage form. Res J Pharm Technol 2014;7:168-72.
Bhadoriya U, Dhaked H, Danodia AK. RP-HPLC method development and validation for estimation of telmisartan in bulk and tablet dosage form. Int J Drug Regul Aff 2013;1:61-4.
Raghu Babu K, Sarma ES, Kumari NA, Raju GM, Sarma GV. Simple and stability indicating RP-HPLC assay method development and validation of telmisartan in bulk and dosage form. Der Pharm Lett 2015;7:274-80.
Patro SK, Kanungo SK, Patro VJ, Choudhury NS. Stability indicating RP-HPLC method for determination of valsartan in pure and pharmaceutical formulation. J Chem 2009;7:487197.
Kore RS, Mahaparale SP, Bhagat AP. Stability indicating RP-HPLC method development and validation for estimation of azilsartan medoxomil in tablet dosage form. World J Pharm Res 2019;8:1023-35.
How to Cite
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.